243
Views
0
CrossRef citations to date
0
Altmetric
Assessment Procedures

Cross-cultural adaptation and validation of Diabetes Quality of Life Brief Clinical Inventory in Turkish patients with type 2 diabetes mellitus

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 995-1004 | Received 17 Aug 2022, Accepted 16 Feb 2023, Published online: 28 Feb 2023

References

  • Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
  • Atlas D. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Vol. 33. Brussels, Belgium: International Diabetes Federation; 2015.
  • Holman N, Young B, Gadsby R. Current prevalence of type 1 and type 2 diabetes in adults and children in the UK. Diabet Med. 2015;9(32):1119–1120.
  • Evans JM, Newton RW, Ruta DA, et al. Socio‐economic status, obesity and prevalence of type 1 and type 2 diabetes mellitus. Diabet Med. 2000;17(6):478–480.
  • Fransen MP, von Wagner C, Essink-Bot M-L. Diabetes self-management in patients with low health literacy: ordering findings from literature in a health literacy framework. Patient Educ Counsel. 2012;88(1):44–53.
  • Babazadeh T, Dianatinasab M, Daemi A, et al. Association of self-care behaviors and quality of life among patients with type 2 diabetes mellitus: Chaldoran County, Iran. Diabetes Metab J. 2017;41(6):449–456.
  • Elkady AAM. Self-care management, emotional distress and self-efficacy: relationships with health-related quality of life among patients with type 2 diabetes. Psycho-Educ Res Rev. 2019;8:73–84.
  • Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15(3):205–218.
  • Keng MJ, Leal J, Bowman L, et al. Decrements in health‐related quality of life associated with adverse events in people with diabetes. Diabetes Obes Metab. 2022;24(3):530–538.
  • Engel-Yeger B, Darawsha Najjar S, Darawsha M. The relationship between health related quality of life and sensory deficits among patients with diabetes mellitus. Disabil Rehabil. 2018;40(25):3005–3011.
  • Chaturvedi R, Desai C, Patel P, et al. An evaluation of the impact of antidiabetic medication on treatment satisfaction and quality of life in patients of diabetes mellitus. Perspect Clin Res. 2018;9(1):15–22.
  • Woodcock AJ, Julious SA, Kinmonth AL, et al. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res. 2001;10(8):661–670.
  • El Achhab Y, Nejjari C, Chikri M, et al. Disease-specific health-related quality of life instruments among adults diabetic: a systematic review. Diabetes Res Clin Pract. 2008;80(2):171–184.
  • Oluchi SE, Manaf RA, Ismail S, et al. Health related quality of life measurements for diabetes: a systematic review. Int J Environ Res Public Health. 2021;18(17):9245.
  • Burroughs TE, Desikan R, Waterman BM, et al. Development and validation of the Diabetes Quality of Life Brief Clinical Inventory. Diabetes Spectrum. 2004;17(1):41–49.
  • Dudzińska M, Tarach JS, Burroughs TE, et al. Validation of the Polish version of Diabetes Quality of Life-Brief Clinical Inventory (DQL-BCI) among patients with type 2 diabetes. Arch Med Sci. 2014;10(5):891.
  • Haider S, Saleem F, Ahmad N, et al. Translation, validation, and psychometric evaluation of the diabetes quality-of-life brief clinical ınventory: the Urdu version. J Multidiscip Healthc. 2022;15:955–966.
  • Irianti SR, Wicaksana AL, Pangastuti HS. Validity and Reliability Test of The Indonesian Version for Diabetes Quality of Life-Brief Clinical Inventory. Indian J Public Health. 2021;12(1):435.
  • Mirfeizi M, Jafarabadi MA, Toorzani ZM, et al. Feasibility, reliability and validity of the Iranian version of the Diabetes Quality of Life Brief Clinical Inventory (IDQOL-BCI). Diabetes Res Clin Pract. 2012;96(2):237–247.
  • Rekleiti M, Souliotis K, Sarafis P, et al. Measuring the reliability and validity of the Greek edition of the Diabetes Quality of Life Brief Clinical Inventory. Diabetes Res Clin Pract. 2018;140:61–71.
  • Samah S, Neoh CF, Wong YY, et al. Linguistic and psychometric validation of the Malaysian version of Diabetes Quality of Life-Brief Clinical Inventory (DQoL-BCI). Res Soc Admin Pharm. 2017;13(6):1135–1141.
  • Tang Z, Jiang X, Hong L, et al. Validation of the Simplified Chinese Version of the Brief Diabetes Quality of Life (DQoL) Questionnaire based on a cross-sectional study. Int J Environ Res Public Health. 2020;17(23):8792.
  • Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191.
  • Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94–104.
  • EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
  • Norris SL. Health-related quality of life among adults with diabetes. Curr Diab Rep. 2005;5(2):124–130.
  • Pequeno NPF, de Araújo Cabral NL, Marchioni DM, et al. Quality of life assessment instruments for adults: a systematic review of population-based studies. Health Qual Life Outcomes. 2020;18(1):1–13.
  • Zhou T, Guan H, Wang L, et al. Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: a systematic review. Front Public Health. 2021;9:802.
  • Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010;8(1):18.
  • Jankowska A, Młyńczak K, Golicki D. Validity of EQ-5D-5L Health-Related Quality of Life Questionnaire in self-reported diabetes: evidence from a general population survey. Health Qual Life Outcomes. 2021;19(1):1–11.
  • Huang IC, Hwang CC, Wu MY, et al. Diabetes‐specific or generic measures for health‐related quality of life? Evidence from psychometric validation of the D‐39 and SF‐36. Value Health. 2008;11(3):450–461.
  • Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.
  • Kahyaoğlu Süt H, Ünsar S. Is EQ-5D a valid quality of life instrument in patients with acute coronary syndrome? Anatol J Cardiol/Anadolu Kardiyol Derg. 2011;11(2):156–162.
  • Lai P. Validating instruments of measure: is it really necessary? Malays Fam Physician. 2013;8(1):2.
  • Pett MA, Lackey NR, Sullivan JJ. Making sense of factor analysis: the use of factor analysis for instrument development in health care research. California (US): Sage; 2003. p. 2–10.
  • Kim H-Y. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38(1):52–54.
  • Bartlett MS. Tests of significance in factor analysis. Br J Psychol. 1950;3:77–85.
  • Cerny BA, Kaiser HF. A study of a measure of sampling adequacy for factor-analytic correlation matrices. Multivariate Behav Res. 1977;12(1):43–47.
  • Rencher AC, Christensen W. Methods of multivariate analysis. New Jersey (US): John Wiley & Sons Inc. Publication; 2002. p. 727.
  • Brown TA. Confirmatory factor analysis for applied research. New York (NY): Guilford Publications; 2015. p. 136–162.
  • Chan F, Lee GK, Lee EJ, et al. Structural equation modeling in rehabilitation counseling research. Rehabil Couns Bull. 2007;51(1):44–57.
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334.
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropract Med. 2016;15(2):155–163.
  • Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
  • de Vet HC, Terwee CB, Knol DL, et al. When to use agreement versus reliability measures. J Clin Epidemiol. 2006;59(10):1033–1039.
  • Kline R. Principles and practice for structural equation modelling. 3rd ed. New York: The Guilford Press; 2011. p. 59–60.
  • Akoglu H. User’s guide to correlation coefficients. Turk J Emerg Med. 2018;18(3):91–93.
  • Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika. 1986;73(3):751–754.
  • McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293–307.
  • Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412.
  • Bowling A, Ebrahim S. Handbook of health research methods: investigation, measurement and analysis. UK: McGraw-Hill Education; 2005. p. 495–533.
  • Williams B, Onsman A, Brown T. Exploratory factor analysis: a five-step guide for novices. Australas J Paramed. 2010;8(3):1–13.
  • Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–55.
  • Kenny DA, McCoach DB. Effect of the number of variables on measures of fit in structural equation modeling. Struct Eq Model. 2003;10(3):333–351.
  • Kline RB. Principles and practice of structural equation modeling. New York (NY): Guilford Publications; 2015.
  • Garratt A, Schmidt L, Fitzpatrick R. Patient‐assessed health outcome measures for diabetes: a structured review. Diabet Med. 2002;19(1):1–11.
  • Hirsch A, Bartholomae C, Volmer T. Dimensions of quality of life in people with non-insulin-dependent diabetes. Qual Life Res. 2000;9(2):207–218.
  • Watkins K, Connell CM. Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics. 2004;22(17):1109–1126.
  • Yildirim A, Akinci F, Gozu H, et al. Translation, cultural adaptation, cross-validation of the Turkish diabetes quality-of-life (DQOL) measure. Qual Life Res. 2007;16(5):873–879.
  • Davis TM, Clifford RM, Davis WA. Effect of insulin therapy on quality of life in type 2 diabetes mellitus: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2001;52(1):63–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.